Actinium Pharmaceuticals, Inc

Go to Actinium Pharmaceuticals, Inc Website

$1.62

-0.04 (-2.41%)
Live
Previous Close

$1.62

Day Range

$1.605 - $1.66

Previous Day Range

$1.62 - $1.675

Market Cap

$51.8 million USD

Day Vol.

82797

Previous Day Vol.

90789

Currency

USD

Primary Exchange

NYSE American, LLC

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to de...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Rosen Law Firm is encouraging investors in Actinium Pharmaceuticals, Inc. (ATNM) who have lost more than $100,000 to seek legal counsel before the May 27 deadline for a securities class action lawsuit. The lawsuit alleges that the company made false and misleading statements about the likelihood of its Iomab-B drug candidate being approved by the FDA.

Related tickers: ATNM.

Read Full Article

Rosen Law Firm is encouraging investors of Actinium Pharmaceuticals, Inc. (ATNM) who have lost more than $100,000 to secure legal counsel before the May 27, 2025 deadline for a securities class action lawsuit.

Related tickers: ATNM.

Read Full Article
Trending Tickers

Please sign in to view